Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery.
Bito S, Miyata S, Migita K, Nakamura M, Shinohara K, Sato T, Tonai T, Shimizu M, Shibata Y, Kishi K, Kubota C, Nakahara S, Mori T, Ikeda K, Ota S, Minamizaki T, Yamada S, Shiota N, Kamei M, Motokawa S. Bito S, et al. Among authors: yamada s. Blood. 2016 Feb 25;127(8):1036-43. doi: 10.1182/blood-2015-06-651620. Epub 2015 Dec 9. Blood. 2016. PMID: 26659923 Free PMC article.
The Efficacy and Safety of Highly-Bioavailable Curcumin for Treating Knee Osteoarthritis: A 6-Month Open-Labeled Prospective Study.
Nakagawa Y, Mukai S, Yamada S, Murata S, Yabumoto H, Maeda T, Akamatsu S. Nakagawa Y, et al. Among authors: yamada s. Clin Med Insights Arthritis Musculoskelet Disord. 2020 Aug 12;13:1179544120948471. doi: 10.1177/1179544120948471. eCollection 2020. Clin Med Insights Arthritis Musculoskelet Disord. 2020. PMID: 32848491 Free PMC article.
Recombinant human FGF-2 for the treatment of early-stage osteonecrosis of the femoral head: TRION, a single-arm, multicenter, Phase II trial.
Kuroda Y, Tanaka T, Miyagawa T, Hamada H, Abe H, Ito-Ihara T, Asada R, Fujimoto Y, Takahashi D, Tetsunaga T, Kaneuji A, Takagi M, Inaba Y, Morita S, Sugano N, Tanaka S, Matsuda S, Akiyama H; TRION trial collaborators:. Kuroda Y, et al. Regen Med. 2021 Jun;16(6):535-548. doi: 10.2217/rme-2021-0049. Epub 2021 Jun 2. Regen Med. 2021. PMID: 34075804 Free article. Clinical Trial.
The Oral Administration of Highly-Bioavailable Curcumin for One Year Has Clinical and Chondro-Protective Effects: A Randomized, Double-Blinded, Placebo-Controlled Prospective Study.
Nakagawa Y, Mori K, Yamada S, Mukai S, Hirose A, Nakamura R. Nakagawa Y, et al. Among authors: yamada s. Arthrosc Sports Med Rehabil. 2022 Jan 13;4(2):e393-e402. doi: 10.1016/j.asmr.2021.10.016. eCollection 2022 Apr. Arthrosc Sports Med Rehabil. 2022. PMID: 35494290 Free PMC article.
Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study.
Nakagawa Y, Mukai S, Yamada S, Matsuoka M, Tarumi E, Hashimoto T, Tamura C, Imaizumi A, Nishihira J, Nakamura T. Nakagawa Y, et al. Among authors: yamada s. J Orthop Sci. 2014 Nov;19(6):933-9. doi: 10.1007/s00776-014-0633-0. Epub 2014 Oct 13. J Orthop Sci. 2014. PMID: 25308211 Free PMC article. Clinical Trial.
8,307 results